Details of the Drug Combinations

General Information of This Drug (ID: DM32B5U)

Drug Name
Upadacitinib   DM32B5U
Synonyms ABT-494
Indication
Disease Entry ICD 11 Status REF
Rheumatoid arthritis FA20 Approved [1]
Psoriatic arthritis FA21 Phase 3 [2]
Atopic dermatitis EA80 Phase 2 [2]
Crohn disease DD70 Phase 2 [3]
Ulcerative colitis DD71 Phase 2 [3]
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Upadacitinib + Prednisolone DCVO48C Prednisolone Takayasu Arteritis (TAK) [4]
------------------------------------------------------------------------------------

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 ClinicalTrials.gov (NCT04161898) A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)